Sueyoshi Ryo, Lane Geoffrey J, Kusafuka Junichi, Yamataka Atsuyuki, Doi Takashi
Department of Pediatric Surgery, Tokyo Bay Urayasu-Ichikawa Medical Center, Urayasu, Chiba, Japan.
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Pediatr Int. 2019 Oct;61(10):1025-1029. doi: 10.1111/ped.13988.
Combination therapy with two different traditional medicine formulations called hainosankyuto and juzentaihoto (TJ-122 and TJ-48; Tsumura & Co, Tokyo, Japan) may be effective for perianal abscess (PA), but their effectiveness has not been established. The present study investigated the effectiveness of combination therapy with TJ-122 and TJ-48 as the most effective conservative treatment for PA.
We identified 69 patients with PA under 2 years of age and divided them into four groups according to the formulations used: group 1, TJ-122 (n = 17); group 2, TJ-48 (n = 14); group 3, TJ-122 and TJ-48 (n = 19); and group 4, no traditional medicines (n = 19). Treatment was continued for 3-6 months after resolution of the PA in groups 1 and 2, and for 1 year in group 3. Age at presentation, duration of purulent discharge (PD), frequency of surgical intervention (incision and drainage [ID]; fistulotomy/fistulectomy), and recurrence rates were statistically analyzed.
Mean age (months) was 8.6 ± 9.2, 6.9 ± 7.3, 5.2 ± 4.7, and 3.8 ± 3.1 in groups 1, 2, 3, and 4, respectively (P = n.s.). Mean PD (weeks) was 2.5 ± 2.2, 7.1 ± 10.8, 2.0 ± 0.0, and 2.7 ± 1.0, respectively. Duration of PD was significantly longer in group 2 than in groups 1 and 3 (P < 0.05). Mean number of ID procedures was 1.0 ± 0.2, 2.3 ± 0.5, 0, and 1.6 ± 0.2, respectively. Group 1 had significantly less ID than group 2 (P < 0.01). Recurrence rates were 6%, 36%, 0%, and 32%, respectively. Groups 1 and 3 had significantly less recurrence than group 2 (P < 0.05), and group 3 had significantly less recurrence than group 4 (P < 0.01).
Combination therapy with TJ-122 and TJ-48 decreased recurrence and surgical intervention to zero in this study, demonstrating high effectiveness for treating PA in children.
两种不同的传统药物配方——柴朴汤(TJ - 122)和十全大补汤(TJ - 48;日本东京津村株式会社)联合治疗肛周脓肿(PA)可能有效,但尚未得到证实。本研究调查了TJ - 122和TJ - 48联合治疗作为PA最有效的保守治疗方法的有效性。
我们确定了69例2岁以下的PA患者,并根据所用配方将他们分为四组:第1组,TJ - 122(n = 17);第2组,TJ - 48(n = 14);第3组,TJ - 122和TJ - 48(n = 19);第4组,不使用传统药物(n = 19)。第1组和第2组在PA消退后持续治疗3 - 6个月,第3组持续治疗1年。对就诊时的年龄、脓性分泌物持续时间(PD)、手术干预频率(切开引流[ID];肛瘘切开术/瘘管切除术)和复发率进行统计学分析。
第1、2、3和4组的平均年龄(月)分别为8.6±9.2、6.9±7.3、5.2±4.7和3.8±3.1(P =无显著差异)。平均PD(周)分别为2.5±2.2、7.1±10.8、2.0±0.0和2.7±1.0。第2组的PD持续时间明显长于第1组和第3组(P < 0.05)。平均ID手术次数分别为1.0±0.2、2.3±0.5、0和1.6±0.2。第1组的ID次数明显少于第2组(P < 0.01)。复发率分别为6%、36%、0%和32%。第1组和第3组的复发率明显低于第2组(P < 0.05),第3组的复发率明显低于第4组(P < 0.01)。
在本研究中,TJ - 122和TJ - 48联合治疗将复发率和手术干预降至零,证明对治疗儿童PA具有高效性。